SUPPLEMENT SCIENCEInsights
Search

Search Insights

Try choline, nano-curcumin or probiotics.

    Ingredient guide · Ingredient reference

    Probiotics and cholesterol: a biomarker question with mixed findings

    Some probiotic studies report modest reductions in total or LDL cholesterol, while others do not. These findings do not establish fewer cardiovascular events or justify replacing cholesterol treatment.

    Read the evidence ↓

    Supplement Science Insights Editorial Team

    Published September 23, 2026

    Some pooled studies show changes in lipid measurements

    ODS describes trials in which certain probiotic preparations reduced total or LDL cholesterol. Other reviews found insufficient evidence for improved lipid levels, particularly when examining different populations and formulations. [1]

    Results therefore should remain attached to the strains, duration and participants studied. A finding for one combination cannot be assigned to every product marketed for heart health. [1]

    Cholesterol change is not itself a cardiovascular-event trial

    LDL is relevant to cardiovascular risk, but a measured change in LDL does not prove that the tested probiotic prevents heart attacks or strokes. Those clinical outcomes require appropriate direct evidence. [1]

    The practical size and durability of a change also matter. A statistically significant laboratory difference can still be small, and it does not establish equivalence to a prescribed treatment. [1]

    Keep the two claims separate

    Imagine a trial reports a lower average LDL value after a defined probiotic course but does not measure heart attacks. It supports discussion of the lipid result within that trial.

    Reporting that the probiotic prevented heart attacks would add an outcome that was not established by the measurement.

    Hypothetical example — two endpoints and a decision
    QuestionInterpretation
    Lower LDL in a studyA lipid measurement
    Fewer cardiovascular eventsA different outcome
    Replace prescribed therapyNot established by the lipid result

    Do not substitute a supplement for risk management

    ODS concludes that more research is needed to confirm the findings. This page does not independently reappraise the trials, rank strains or select an individual treatment. [1]

    A person taking cholesterol medication should not stop it because of a probiotic claim. Overall cardiovascular risk and the existing plan remain separate clinical considerations. [1]

    Probiotics and cholesterol: a biomarker question with mixed findings — original article outline diagram
    Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

    Sources for this article

    1. NIH ODS: Probiotics
      Source consulted: 2026-09-17. This is a reference resource, not a claim that we conducted the studies or tested a product.